A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether gabapentin enacarbil (XP13512/GSK1838262),
hereafter referred to as GEn is effective in the treatment of neuropathic pain associated
with diabetic peripheral neuropathy(DPN)